Patents by Inventor Mervin Yoder

Mervin Yoder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10563175
    Abstract: The present disclosure relates generally to methods and compositions useful in cell and tissue biology and therapeutics. In particular, an in vitro method for differentiating pluripotent cells into endothelial colony forming cell-like cells (ECFC-like cells) is provided. A purified human cell population of NRP-1+CD31+ ECFC-like cells is provided, wherein at least some of the cells in the population have a high proliferation potential. Therapeutic and test agent screening methods for using the cell populations of the present disclosure are provided.
    Type: Grant
    Filed: March 11, 2015
    Date of Patent: February 18, 2020
    Assignee: Indiana University Research and Technology Corporation
    Inventors: Mervin Yoder, Nutan Prasain
  • Publication number: 20170022476
    Abstract: The present disclosure relates generally to methods and compositions useful in cell and tissue biology and therapeutics. In particular, an in vitro method for differentiating pluripotent cells into endothelial colony forming cell-like cells (ECFC-like cells) is provided. A purified human cell population of NRP-1+CD31+ ECFC-like cells is provided, wherein at least some of the cells in the population have a high proliferation potential. Therapeutic and test agent screening methods for using the cell populations of the present disclosure are provided.
    Type: Application
    Filed: March 11, 2015
    Publication date: January 26, 2017
    Inventors: Mervin Yoder, Nutan Prasain
  • Patent number: 8573360
    Abstract: The roof jacking seat system is inclusive of a seat pivotally oriented with respect to a wheeled frame such that said seat can adjust in accommodation of different roof pitches. The system is for the support of an end user atop of said roof during roof shingle removal processes. The frame includes a winching means having a cable and hook for engagement onto a roof ridge such that the entire system may be driven up or down a side of said roof. The frame includes a plurality of wheels in parallel orientation thereby enabling movement along a single axis. Pivoting means enables adjustment of the seat at different angles with respect to the frame. The frame may include along a distal end, a footrest for use by the end user.
    Type: Grant
    Filed: November 8, 2011
    Date of Patent: November 5, 2013
    Inventor: Mervin Yoder
  • Publication number: 20080025956
    Abstract: Methods and compositions to form fully functional blood vessels in vivo using endothelial colony forming cells (ECFCs) are disclosed. Culturing ECFCs in a support material results in association of ECFCs in vitro and formation of blood vessels in vivo upon implantation. Direct administration of cultured ECFCs form blood vessels in vivo. Formation of blood vessels is useful in treating a variety of medical conditions including ischemia and hypoxia.
    Type: Application
    Filed: August 13, 2007
    Publication date: January 31, 2008
    Applicant: Indiana University Research and Technology Corporation
    Inventors: Mervin Yoder, David Ingram, Daniel Prater
  • Publication number: 20050266556
    Abstract: A hierarchy of endothelial colony forming cells (EPCs) was identified from mammalian cord blood, umbilical vein and aorta. A newly isolated cell named high proliferative potential—endothelial colony forming cell (HPP-ECFC) was isolated and characterized. Single cell assays were developed that test the proliferative and clonogenic potential of endothelial cells derived from cord blood, or from HUVECs and HAECs. EPCs were found to reside in vessel walls. Use of a feeder layer of cells derived from high proliferative potential-endothelial colony forming cells (HPP-ECPCS) from human umbilical cord blood, stimulates growth and survival of repopulating hematopoietic stem and progenitor cells. Stimulation of growth and survival was determined by increased numbers of progenitor cells in in vitro cultures and increased levels of human cell engraftment in the NOD/SCID immunodeficient mouse transplant system.
    Type: Application
    Filed: February 9, 2005
    Publication date: December 1, 2005
    Inventors: Mervin Yoder, David Ingram